These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30089426)

  • 1. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
    Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
    Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
    Barnett ML; Lee D; Frank RG
    Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
    Andrilla CHA; Jones KC; Patterson DG
    J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
    Andrilla CHA; Coulthard C; Patterson DG
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.
    Auty SG; Stein MD; Walley AY; Drainoni ML
    J Subst Abuse Treat; 2020 Aug; 115():108032. PubMed ID: 32600629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which family physicians work routinely with nurse practitioners, physician assistants or certified nurse midwives.
    Peterson LE; Blackburn B; Petterson S; Puffer JC; Bazemore A; Phillips RL
    J Rural Health; 2014; 30(3):227-34. PubMed ID: 24330195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.
    Andraka-Christou B; Gordon AJ; Spetz J; Totaram R; Golan M; Randall-Kosich O; Harrison J; Calder S; Kertesz SG; Stein BD
    J Subst Abuse Treat; 2022 Jul; 138():108715. PubMed ID: 35067400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
    Andrilla CHA; Coulthard C; Larson EH
    Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort study.
    Klein TA; Hartung D; Markwardt S
    Subst Abuse Treat Prev Policy; 2022 Jan; 17(1):5. PubMed ID: 35101077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
    Andraka-Christou B; Page C; Schoebel V; Buche J; Haffajee RL
    Addict Sci Clin Pract; 2022 Aug; 17(1):43. PubMed ID: 35945636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder.
    Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S
    J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice.
    Murphy J; Goodman D; Johnson MC; Terplan M
    Obstet Gynecol; 2018 Mar; 131(3):542-544. PubMed ID: 29420414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician assistant and nurse practitioner prescribing: 1997-2002.
    Hooker RS; Cipher DJ
    J Rural Health; 2005; 21(4):355-60. PubMed ID: 16294660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of physicians, physician assistants, and nurse practitioners toward rural primary care: findings from a 13-state survey.
    Doescher MP; Andrilla CH; Skillman SM; Morgan P; Kaplan L
    Med Care; 2014 Jun; 52(6):549-56. PubMed ID: 24824539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters.
    Quest TL; Merrill JO; Roll J; Saxon AJ; Rosenblatt RA
    J Opioid Manag; 2012; 8(1):29-38. PubMed ID: 22479882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.